Vivos Therapeutics VVOS
NASDAQ VVOS
$0.13 +0.00 (+0.91%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Selling, General & Administrative (2020 - 2026)

Updated

Vivos Therapeutics (VVOS) posted Selling, General & Administrative of $7.11 million for Q2 2026, up 11.0% from $6.41 million a year earlier but down 20.7% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Vivos Therapeutics was $32.51 million, up 61.5% year-over-year; for FY2025, it was $27.73 million, up 55.1% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
  • In prior years, Vivos Therapeutics' Selling, General & Administrative was $17.88 million in FY2024 (-20.5%), $22.48 million in FY2023 (-22.6%), $29.04 million in FY2022 (+12.6%) and $25.79 million in FY2021 (+60.3%).
  • Quarterly Selling, General & Administrative has run from a low of $4.12 million in Q2 2024 to a high of $8.97 million in Q1 2026 over five years.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last five quarters, with growth averaging 37.3% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2025, with growth of 96.6%; the weakest was Q3 2023, with a decline of 30.6%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $8.97 million (Q1 2026), $8.55 million (Q4 2025) and $7.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn 2.33 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn 4.03 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn 2.07 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn 633.40 Mn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn 3.20 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn 2.23 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn 1.80 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn 1.26 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn 561.20 Mn
10 Vivos Therapeutics 2.37 Mn -6.67 Mn 2.95 Mn 7.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.11 Mn
Mar 31, 2026 8.97 Mn
Dec 31, 2025 8.55 Mn
Sep 30, 2025 7.88 Mn
Jun 30, 2025 6.41 Mn
Mar 31, 2025 4.89 Mn
Dec 31, 2024 4.35 Mn
Sep 30, 2024 4.49 Mn
Jun 30, 2024 4.12 Mn
Mar 31, 2024 4.92 Mn
Dec 31, 2023 5.47 Mn
Sep 30, 2023 4.60 Mn
Jun 30, 2023 5.88 Mn
Mar 31, 2023 6.54 Mn
Dec 31, 2022 6.92 Mn
Sep 30, 2022 6.62 Mn
Jun 30, 2022 7.69 Mn
Mar 31, 2022 8.28 Mn
Dec 31, 2021 8.12 Mn
Sep 30, 2021 6.52 Mn
API Access

Vivos Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VVOS&period=max&api_key=YOUR_API_KEY